Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo

International Journal of Obesity

Volumn 40, Issue 5, 2016, Pages 861-869

  Bhatia, H ^a   Pattnaik, B R ^a   Datta, M ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; FAT DROPLET; FATTY ACID SYNTHASE; GLUCOSE; HEAT SHOCK COGNATE PROTEIN 70; LAMIN A; LAMIN C; MEMBRANE PROTEIN; MICRORNA 107; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL; TUNICAMYCIN; VERY LOW DENSITY LIPOPROTEIN; VINCULIN; FATTY ACID; MICRORNA; MIRN107 MICRORNA, MOUSE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL CULTURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; FATTY ACID OXIDATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLUCOSE BLOOD LEVEL; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; IN VIVO STUDY; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; MALE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; C57BL MOUSE; DISEASE MODEL; FATTY LIVER; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE INTOLERANCE; IMMUNOHISTOCHEMISTRY; LIPOGENESIS; LIVER; LIVER CELL; METABOLISM; MITOCHONDRION; OXIDATION REDUCTION REACTION; PATHOLOGY; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM STRESS; FATTY ACIDS; FATTY LIVER; GENE EXPRESSION REGULATION; GLUCOSE INTOLERANCE; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; LIPOGENESIS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MITOCHONDRIA; OXIDATION-REDUCTION;

EID: 84955250545     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.225     Document Type: Article

References (52)

1. Stefan N, Kantartzis K, Haring HU. Causes and metabolic consequences of Fatty liver. Endocrine Rev 2008; 29: 939-960.
2. Bhatia H, Verma G, Datta M. miR-107 orchestrates ER stress induction and lipid accumulation by post-transcriptional regulation of fatty acid synthase in hepatocytes. Biochim Biophys Acta 2014; 1839: 334-343.
3. Jin X, Ye YF, Chen SH, Yu CH, Liu J, Li YM. MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease. Dig Liver Dis 2009; 41: 289-297.
4. Li S, Chen X, Zhang H, Liang X, Xiang Y, Yu C et al. Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. J Lipid Res 2009; 50: 1756-1765.
5. Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 2011; 474: 649-653.
6. Cheung O, Puri P, Eicken C, Contos MJ, Mirshahi F, Maher JW et al. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology 2008; 48: 1810-1820.
7. Kaur K, Pandey AK, Srivastava S, Srivastava AK, Datta M. Comprehensive miRNome and in silico analyses identify the Wnt signaling pathway to be altered in the diabetic liver. Mol BioSys 2011; 7: 3234-3244.
8. Fang DL, Wan Y, Shen W, Cao J, Sun ZX, Yu HH et al. Endoplasmic reticulum stress leads to lipid accumulation through upregulation of SREBP-1c in normal hepatic and hepatoma cells. Mol Cell Biochem 2013; 381: 127-137.
9. Zhang C, Chen X, Zhu RM, Zhang Y, Yu T, Wang H et al. Endoplasmic reticulum stress is involved in hepatic SREBP-1c activation and lipid accumulation in fructose-fed mice. Toxicol Lett 2012; 212: 229-240.
10. Lee CH, Olson P, Evans RM. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 2003; 144: 2201-2207.
11. Lee J-S, Mendez R, Heng HH, Yang Z-q, Zhang K. Pharmacological ER stress promotes hepatic lipogenesis and lipid droplet formation. Am J Transl Res 2012; 4: 102-113.
12. Murphy DJ, Vance J. Mechanisms of lipid-body formation. Trends Biochem Sci 1999; 24: 109-115.
13. Fei W, Wang H, Fu X, Bielby C, Yang H. Conditions of endoplasmic reticulum stress stimulate lipid droplet formation in Saccharomyces cerevisiae. Biochem J 2009; 424: 61-67.
14. Choe YG, Jin W, Cho YK, Chung WG, Kim HJ, Jeon WK et al. Apolipoprotein B/AI ratio is independently associated with non-alcoholic fatty liver disease in non-diabetic subjects. J Gastroenterol Hepatol 2013; 28: 678-683.
15. Qiu W, Zhang J, Dekker MJ, Wang H, Huang J, Brumell JH et al. Hepatic autophagy mediates endoplasmic reticulum stress-induced degradation of misfolded apolipoprotein B. Hepatology 2011; 53: 1515-1525.
16. Ota T, Gayet C, Ginsberg HN. Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. J Clin Invest 2008; 118: 316-332.
17. Marin-Garcia J, Goldenthal MJ. Fatty acid metabolism in cardiac failure: biochemical, genetic and cellular analysis. Cardiovar Res 2002; 54: 516-527.
18. Amako Y, Munakata T, Kohara M, Siddiqui A, Peers C, Harris M. Hepatitis C virus attenuates mitochondrial lipid β-oxidation by downregulating mitochondrial trifunctional-protein expression. J Virol 2015; 89: 84092-84101.
19. Garcia-Ruiz C, Baulies A, Mari M, Garcia-Roves PM, Fernandez-Checa JC. Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence? Free Rad Res 2013; 47: 854-868.
20. Hsu SH, Yu B, Wang X, Lu Y, Schmidt CR, Lee RJ et al. Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor. Nanomedicine 2013; 9: 1169-1180.
21. Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res 2010; 70: 5923-5930.
22. Osorio FG, de la Rosa J, Freije JMP. Luminiscence-based in vivo monitoring of NF-κB activity through a gene delivery approach. Cell Comm Sig 2013; 11: 19.
23. Chang RM, Yang H, Fang F, Xu JF, Yang LY. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase. Hepatology 2014; 60: 1251-1263.
24. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acid Res 2001; 29: e45.
25. Mehlem A, Hagberg CE, Muhl L, Eriksson U, Falkevall A. Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease. Nat Protoc 2013; 8: 1149-1154.
26. Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science 2011; 332: 1519-1523.
27. Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008; 118: 829-838.
28. Zhang F, Xu X, Zhang Y, Zhou B, He Z, Zhai Q. Gene expression profile analysis of type 2 diabetic mouse liver. PLoS One 2013; 8: e57766.
29. Desvergne B, Michalik L, Wahli W. Transcriptional regulation of metabolism. Physiol Rev 2006; 86: 465-514.
30. Yamamoto K, Takahara K, Oyadomari S, Okada T, Sato T, Harada A et al. Induction of liver steatosis and lipid droplet formation in ATF6alpha-knockout mice burdened with pharmacological endoplasmic reticulum stress. Mol Biol Cell 2010; 21: 2975-2986.
31. Eaton S, Bartlett K, Pourfarzam M. Mammalian mitochondrial β-oxidation. Biochem J 1996; 320: 345-357.
32. Sunny NE, Parks EJ, Browning JD, Burgess SC. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab 2011; 14: 804-810.
33. Kammoun HL, Chabanon H, Hainault I, Luquet S, Magnan C, Koike T et al. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest 2009; 119: 1201-1215.
34. Chang YS, Tsai CT, Huangfu CA, Huang WY, Lei HY, Lin CF et al. ACSL3 and GSK-3beta are essential for lipid upregulation induced by endoplasmic reticulum stress in liver cells. J Cell Biochem 2011; 112: 881-893.
35. Jo H, Choe SS, Shin KC, Jang H, Lee JH, Seong JK et al. Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic very low-density lipoprotein receptor. Hepatology 2013; 57: 1366-1377.
36. Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006; 313: 1137-1140.
37. Rutkowski DT, Wu J, Back SH, Callaghan MU, Ferris SP, Iqbal J et al. UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. Dev Cell 2008; 15: 829-840.
38. Nagle CA, Klett EL, Coleman RA. Hepatic triacylglycerol accumulation and insulin resistance. J Lipid Res 2009; 50: S74-S79.
39. Nakamura S, Takamura T, Matsuzawa-Nagata N, Takayama H, Misu H, Noda H et al. Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J Biol Chem 2009; 284: 14809-14818.
40. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O et al. Mito-chondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008; 7: 45-56.
41. Vickers KC, Shoucri BM, Levin MG, Wu H, Pearson DS, Osei-Hwedieh D et al. MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia. Hepatology 2013; 57: 533-542.
42. Cheung L, Gertow J, Werngren O, Folkersen L, Petrovic N, Nedergaard J et al. Human mediastinal adipose tissue displays certain characteristics of brown fat. Nutr Diabetes 2013; 3: e66.
43. Svensson PA, Jernås M, Sjöholm K, Hoffmann JM, Nilsson BE, Hansson M et al. Gene expression in human brown adipose tissue. Int J Mol Med 2011; 27: 227-232.
44. Mancina RM, Burza MA, Maglio C, Pirazzi C, Sentinelli F, Incani M et al. The COBLL1 C allele is associated with lower serum insulin levels and lower insulin resistance in overweight and obese children. Diab Metab Res Rev 2013; 29: 413-416.
45. Chen HH, Keyhanian K, Zhou X, Vilmundarson RO, Almontashiri NA, Cruz S et al. IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis. Circ Res 2015; 117: 671-683.
46. Koeppel M, van Heeringen SJ, Smeenk L, Navis AC, Janssen-Megens EM, Lohrum M. The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response. Nuc Acid Res 2009; 37: 322-335.
47. Yahagi N, Shimano H, Matsuzaka T, Sekiya M, Najima Y, Okazaki S et al. p53 Involvement in the Pathogenesis of Fatty Liver Disease. J Biol Chem 2004; 279: 20571-20575.
48. Vig S, Talwar P, Kaur K, Srivastava R, Srivastava AK, Datta M. Transcriptome profiling identifies p53 as a key player during calreticulin deficiency: Implications in lipid accumulation. Cell Cycle 2015; 14: 2274-2284.
49. Gao J, Ye H, Serrero G. Stimulation of Adipose Differentiation related Protein (ADRP) expression in adipocyte precursors by long chain fatty acids. J cell Physiol 2000; 182: 297-302.
50. Tobin KA, Harsem NK, Dalen KT, Staff AC, Nebb HI, Duttaroy AK. Regulation of ADRP expression by long-chain polyunsaturated fatty acids in BeWo cells, a human placental choriocarcinoma cell line. J Lipid Res 2006; 47: 815-823.
51. Nagle CA, An J, Shiota M, Torres TP, Cline GW, Liu ZX et al. Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance. J Biol Chem 2007; 282: 14807-14815.
52. Flamment M, Hajduch E, Ferre P, Foufelle F. New insights into ER stress-induced insulin resistance. Trends Endocrinol Metab 2012; 23: 381-390.